Memphasys Ltd MEM
ASX · Australia · Health Technology
AUD 0.0050000.00 (0.00%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Memphasys Ltd (ASX:MEM, OTC:MPHSF, FRA:IG7) has executed a 12-month exclusive national supply agreement with Monash IVF Group Ltd (ASX:MVF) (ASX) for the rollout of its Felix™ automated sperm selection system across Australia. The agreement follows more than 10 years of collaboration between...
Memphasys Ltd (ASX:MEM, OTC:MPHSF, FRA:IG7) has secured its first commercial partnership in South-East Asia, signing an exclusive agreement with TMSC Viet Nam Medical Technology Company Limited for the sale and distribution of its Felix™ sperm separation system in Vietnam. The two-year...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.